Genfit SA (NASDAQ:GNFT)
| 3.36 Delayed Data As of May 24 |  -0.30 / -8.20%Today’s Change | 3.01 Today|||52-Week Range 6.38 | -32.80% Year-to-Date |
Latest GNFT News | Press Releases
No recent news for Genfit SA.
Today’s Trading
| Previous close | 3.66 |
| Today’s open | 3.52 |
| Day’s range | 3.35 - 3.52 |
| Volume | 410 |
| Average volume (3 months) | 17,783 |
| Market cap | $255.1M |
Data as of 4:00pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -146.88% |
| Earnings growth (next 5 years) | +37.40% |
| Revenue growth (last year) | +10,752.21% |
| P/E ratio | 2.5 |
| Price/Sales | 2.94 |
| Price/Book | 1.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OMEROmeros Corp | -0.24 | -8.28% |
| IMUXImmunic Inc | +0.05 | +0.83% |
| ---- | ||
| WWHCW World Corp | +0.04 | +2.22% |
Data as of 4:00pm ET, 05/24/2022
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $94.6M |
| Annual profit (last year) | $79.5M |
| Net profit margin | 84.00% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Loos, Hauts-de-france |
Forecasts
